Evidence map›Paper›PMID 31277105›Full record

ArticleMedicine2019

Differentiation of postoperative changes and residual tumors in dynamic contrast-enhanced sella MRI after transsphenoidal resection of pituitary adenoma.

Ha Youn Kim, Sung Tae Kim, Hyung-Jin Kim, Pyoung Jeon, Hong Sik Byun, Yi Kyung Kim, Jihoon Cha, Gyeong Min Park, Do-Hyun Nam, Doo-Sik Kong

Abstract read
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ha Youn KimDepartment of Radiology, Eulji University Hospital, Daejeon.
Sung Tae KimDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Hyung-Jin KimDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Pyoung JeonDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Hong Sik ByunDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Yi Kyung KimDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Jihoon ChaDepartment of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul.
Gyeong Min ParkDepartment of Radiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan.
Do-Hyun NamDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Doo-Sik KongDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To establish magnetic resonance imaging (MRI) features that differentiate residual tumors from postoperative surgical changes following the transsphenoidal approach of a pituitary adenoma.We analyzed residual enhancements at the tumor bed in 52 patients who underwent dynamic contrast-enhanced sella MRI within 48 hours after surgery and at 6 to 28 months. Patients were divided into 2 groups defined by either peripheral or nodular enhancement patterns. For each group, we measured the maximum thickness of the residual enhancing portion and compared differences in the residual tumor and postoperative changes.Among the tumors examined in the 52 patients, 19 residual tumors showed nodular (n = 16) and peripheral (n = 3) enhancement patterns, and 33 postoperative changes showed nodular (n = 3) and peripheral (n = 30) enhancement patterns. The mean residual tumor thickness was 7.1 mm (range, 2.9-16.8 mm) and 1.9 mm (range, 1.0-7.4 mm) in the postoperative change. Receiver operating characteristic curve analysis revealed that a 3.9-mm thickness was associated with 89% sensitivity, 97% specificity, and 94% accuracy for diagnosis of residual tumor.On immediate postoperative MRI, residual enhancement with greater than 3.9-mm thickness and nodular pattern suggest residual pituitary adenoma tumor.

Indexed as

AdenomaAdolescentAdultAgedDiffusion Magnetic Resonance ImagingFemaleHumansMaleMiddle AgedNeoplasm, ResidualPituitary NeoplasmsRetrospective StudiesSella TurcicaYoung Adult

Identifiers

PMID31277105
PMCPMC6635295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.